Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1992 Jan;50(1):195–198.

A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.

D R Jacobson 1
PMCID: PMC1682535  PMID: 1729888

Abstract

The variant transthyretin (TTR) allele, TTR (122 Val----Ile), associated with cardiac amyloidosis in blacks, is caused by a G----A transition which destroys a MaeIII site. This variant has previously been detected by PCR around codon 122, followed by MaeIII digestion, but this test is not specific: any of 12 mutations in the MaeIII recognition site, each of which yields a different amino acid change, would also destroy this site. A modification of PCR, termed "PCR-primer-introduced restriction analysis," was used to introduce a new FokI site into the PCR products derived from the variant (122 Ile) but not wild-type (122 Val) allele. This test demonstrated that each of six previously identified MaeIII(-) alleles had lost its MaeIII site because of a G----A transition encoding TTR (122 Val----Ile), confirming that the same TTR variant was present both in 4/177 healthy black individuals and as a homozygous variant in an individual with cardiac amyloidosis.

Full text

PDF
195

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gorevic P. D., Prelli F. C., Wright J., Pras M., Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest. 1989 Mar;83(3):836–843. doi: 10.1172/JCI113966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Haliassos A., Chomel J. C., Grandjouan S., Kruh J., Kaplan J. C., Kitzis A. Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res. 1989 Oct 25;17(20):8093–8099. doi: 10.1093/nar/17.20.8093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jacobson D. R., Buxbaum J. N. Genetic aspects of amyloidosis. Adv Hum Genet. 1991;20:69-123, 309-11. doi: 10.1007/978-1-4684-5958-6_2. [DOI] [PubMed] [Google Scholar]
  4. Jacobson D. R., Gorevic P. D., Buxbaum J. N. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet. 1990 Jul;47(1):127–136. [PMC free article] [PubMed] [Google Scholar]
  5. Jacobson D. R., Moskovits T. Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA) PCR Methods Appl. 1991 Nov;1(2):146–148. doi: 10.1101/gr.1.2.146. [DOI] [PubMed] [Google Scholar]
  6. Jacobson D. R., Reveille J. D., Buxbaum J. N. Frequency and genetic background of the position 122 (Val----Ile) variant transthyretin gene in the black population. Am J Hum Genet. 1991 Jul;49(1):192–198. [PMC free article] [PubMed] [Google Scholar]
  7. Nichols W. C., Liepnieks J. J., Snyder E. L., Benson M. D. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med. 1991 Mar;117(3):175–180. [PubMed] [Google Scholar]
  8. Saraiva M. J., Sherman W., Marboe C., Figueira A., Costa P., de Freitas A. F., Gawinowicz M. A. Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant. Scand J Immunol. 1990 Oct;32(4):341–346. doi: 10.1111/j.1365-3083.1990.tb02928.x. [DOI] [PubMed] [Google Scholar]
  9. Tsuzuki T., Mita S., Maeda S., Araki S., Shimada K. Structure of the human prealbumin gene. J Biol Chem. 1985 Oct 5;260(22):12224–12227. [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES